Overview

Study to Test the Blood to See if a New Medicine is Likely to Provide Pain Relief Similar to a Product Already Sold in Stores

Status:
Completed

Trial end date:
2012-03-01

Target enrollment:

Participant gender:

Summary

This study is designed to assess bioequivalence between one test and one reference formulation used for temporary relief of pain. The results will help decide if the new medicine is likely to provide pain relief similar to the product being sold.

Phase:

Phase 1

Details

Lead Sponsor:

McNeil AB

Treatments:

Ibuprofen